EXEMASIN-25 BOX

Exemasin 25 (containing Exemestane 25 mg) is a brand-name pharmaceutical product manufactured primarily in South Asia such as India by POWERBOLIC LAB. Across different countries and regulatory frameworks, its active ingredient (Exemestane) is prescribed for distinct medical purposes.

1. Approved Medical Purpose (Worldwide)

In virtually all countries with medical approvals (including the US FDA, UK MHRA, EMA in Europe, and CDSCO in India), Exemestane 25 mg is classified as a steroidal irreversible aromatase inhibitor.

1. Hormone Receptor-Positive (HR+) Breast Cancer: Its universal clinical purpose is to treat postmenopausal women with early or advanced hormone-sensitive breast cancer.
2. Mechanism: It permanently binds to and disables the aromatase enzyme, which converts androgens into estrogen. By drastically lowering circulating estrogen levels, it starves estrogen-dependent cancer cells, inhibiting tumor growth and preventing recurrence.
3. Sequential Protocol: It is frequently prescribed as adjuvant therapy following 2 to 3 years of initial treatment with Tamoxifen.

2. Country-Specific Overview & Regulatory Status

Depending on the country or region, the brand name, distribution, and clinical regulations for Exemestane 25 mg vary:

India & South Asia

1. Primary Brand: Sold directly as Exmest / Exemasin 25 mg.

1. Indication: Widely prescribed for postmenopausal breast cancer management under national oncology guidelines.

United States & Canada

1. Brand Equivalence: Known under the brand name Aromasin (Pfizer) or generic Exemestane 25 mg tablets.
2. FDA Status: Approved strictly for early HR+ breast cancer (adjuvant) and advanced HR+ breast cancer progressing after tamoxifen therapy.

United Kingdom & European Union

1. Regulatory Oversight: Approved by the European Medicines Agency (EMA) and UK MHRA.
2. Indication: Adjuvant treatment of postmenopausal women with estrogen receptor-positive early invasive breast cancer and advanced disease.

Steroidal aromatase inhibitor that suppresses estrogen production, primarily used in hormone-sensitive breast cancer.

Exemestane works by permanently binding to and inactivating the enzyme aromatase (a process called suicide inhibition). Aromatase converts androgens into estrogens in peripheral tissues. By blocking this conversion, exemestane reduces circulating estrogen levels, starving estrogen-dependent tumor cells of the hormones needed to grow.

Dosage & Administration

1. Standard Dosage: 25 mg taken orally once daily.
2. Timing: Take after a meal, as dietary fat significantly enhances drug absorption.
3. Duration: Typically prescribed for several years as determined by an oncologist (often completing a total of 5 years of adjuvant hormone therapy when combined with initial tamoxifen treatment).